From: Molecular and clinicopathologic features of gliomas harboring NTRK fusions
Case | Age (years) | Histologic diagnosis | NTRK fusion | Match to known methylation family? | Closest methylation family match | Methylation family score |
---|---|---|---|---|---|---|
1 | 24 | Low grade glioma | NBPF20-NTRK2 | No | LGG, DNT | 0.6959 |
2 | 16 | Glioma with anaplastic features | SPECC1L-NTRK2 | No | DMG, K27 | 0.4858 |
3 | 0.42 | High grade glioma with features of pleomorphic xanthoastrocytoma | TRIM24-NTRK2 | Yes | PXA | 0.989 |
4 | 6 | Low grade glioma | GKAP1-NTRK2 | No | MTGF_PA | 0.3584 |
5 | 0.23 | High grade glioma | EML1-NTRK2 | No | MTGF_PLEX_T | 0.4474 |
6 | 4 | Glioma with anaplastic features | ETV6-NTRK3 | No | MTGF_PLEX_T | 0.5473 |
7 | 42 | Anaplastic ependymoma, WHO grade 3 | MYO5A-NTRK3 | No | MTGF_PLEX_T | 0.19 |
8 | 42 | Glioblastoma, WHO grade 4 | CD247-NTRK1 | N/A | N/A | N/A |
9 | 43 | Glioblastoma, WHO grade 4 | LMNA-NTRK1 | No | MTGF_GBM | 0.6923 |
10 | 31 | High grade glioma | ARHGEF2-NTRK1 | No | DLGNT | 0.2434 |
11 | 27 | Glioblastoma, WHO grade 4 | BCR-NTRK2 | N/A | N/A | N/A |
12 | 38 | Anaplastic astrocytoma, WHO grade 3 | FRY-NTRK3 | No | MTGF_PLEX_T | 0.4062 |
13 | 54 | Glioblastoma, WHO grade 4 | KIAA1199-NTRK3 | N/A | N/A | N/A |
14 | 0.25 | Glioblastoma, WHO grade 4 | ETV6-NTRK3 | Yes | IHG | 0.9836 |
15 | 2.7 | Anaplastic pilocytic astrocytoma | KANK1-NTRK2 | No | PXA | 0.7403 |
16 | 7 | Ganglioglioma, WHO grade 1 | KCTD16-NTRK2 | No | MTGF_PA | 0.2699 |
17 | 9 | Ganglioglioma, WHO grade 1 | TRIM24-NTRK2 | No | MTGF_PA | 0.6814 |
18 | 16 | Diffuse astrocytoma, WHO grade 2 | QKI-NTRK2 | N/A | N/A | N/A |
19 | 2 | Glioma with anaplastic features | TPR and NTRK1 | No | MTGF_PA | 0.3765 |
20 | <1 | Glioblastoma, WHO grade 4 | ETV6-NTRK3 | No | MTGF_PLEX_T | 0.1241 |
21 | 1.83 | High grade glioma | KIF21B-NTRK1 | No | MTGF_GBM | 0.773 |
22 | 7 | Glioma with anaplastic features | TNS3-NTRK2 | No | DLGNT | 0.6739 |
23 | 55 | Anaplastic astrocytoma, WHO grade 3 | ARGLU1-NTRK1 | N/A | N/A | N/A |
24 | <1 | Glioblastoma, WHO grade 4 | NOS1AP-NTRK1 | N/A | N/A | N/A |
25 | 16 | Pilocytic astrocytoma, WHO grade 1 | AFAP1-NTRK2 | N/A | N/A | N/A |
26 | 26 | Diffuse astrocytoma, WHO grade 2 | NTRK1-NFASC | N/A | N/A | N/A |
27 | 48 | Glioblastoma, WHO grade 4 | BCAN-NTRK1 | N/A | N/A | N/A |
28 | 8 | Glioblastoma, WHO grade 4 | BCR-NTRK2 | N/A | N/A | N/A |
29 | 79 | Glioblastoma, WHO grade 4 | ARHGEF11-NTRK1 | N/A | N/A | N/A |
30 | 59 | Glioblastoma, WHO grade 4 | BCAN-NTRK1 | N/A | N/A | N/A |
31 | 54 | Glioblastoma, WHO grade 4 | BCAN-NTRK1 | N/A | N/A | N/A |
32 | 24 | Pilocytic astrocytoma, WHO grade 1 | BCAN-NTRK1 | N/A | N/A | N/A |
33 | 3 | Desmoplastic infantile ganglioglioma, WHO grade 1 | TPM3-NTRK1 | N/A | N/A | N/A |
34 | 52 | Glioblastoma, WHO grade 4 | DLG1-NTRK3 | N/A | N/A | N/A |
35 | 1 | High grade glioma | ETV6-NTRK3 | N/A | N/A | N/A |
36 | <1 | Glioblastoma, WHO grade 4 | TPM3-NTRK1 | N/A | N/A | N/A |
37 | 63 | Glioblastoma, WHO grade 4 | TPM3-NTRK1 | N/A | N/A | N/A |
38 | 78 | Glioblastoma, WHO grade 4 | TPM3-NTRK1 | N/A | N/A | N/A |
39 | 45 | Glioblastoma, WHO grade 4 | PAIP1-NTRK2 | N/A | N/A | N/A |
40 | 31 | Glioblastoma, WHO grade 4 | ARHGEF2-NTRK1 | N/A | N/A | N/A |
41 | 81 | Glioblastoma, WHO grade 4 | LMNA-NTRK1 | N/A | N/A | N/A |
42 | 44 | Glioblastoma, WHO grade 4 | CHTOP-NTRK1 | N/A | N/A | N/A |